DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20201776

Gynaecological malignancies in Azare, North-East Nigeria: an assessment of types, stage at presentation and treatment affordability

Muhammad B. Aminu, Sanusi M. Ibrahim, Nasiru A. Garba, Nasiru I. Umar, Nighat Khan, Hadiza A. Usman

Abstract


Background: In many parts of the world, presentations for most gynecological cancers are late; this makes treatment difficult due to the cost of chemotherapy or radiotherapy which form the bedrock for cure or palliation. Objective of this study was to determine the types, stage at diagnosis, affordability of care and outcome of treatment of gynaecological cancers in Federal Medical Centre Azare, Bauchi State, Nigeria.

Methods: All cases of gynaecological cancers seen over a ten-year period, from 1st January, 2003 to 31st December, 2012 were reviewed retrospectively. The number of all gynaecological cases seen during the period was also extracted.

Results: Gynaecological cancer cases accounted for 11.84 % of 8,642 gynaecological cases seen during the period of study.  The mean age and parity of the women were 42±5 SD years and 5±1 SD respectively. Cervical cancer accounted for 55 %, ovarian cancer 30%, endometrial cancer 6%, choriocarcinoma 5%, secondaries/ cancers of undetermined origin were 4%.  Ninety-two percent presented with advanced stage of diseases. Only 25.3% could afford the cost of full treatment, and 8.4% attained cure of their disease. The modalities of treatment available were surgery and chemotherapy.

Conclusions: Cervical and Ovarian Cancers remain the leading types of gynaecological cancers in our environment and late presentations are frequent occurrence. Late presentation and unaffordability of treatments are major challenges associated with the management of these patients. Early presentation and funding mechanisms for gynaecological cancers are keys to improved cure rate and reduced mortality.


Keywords


Gynaecological malignancies, Late presentation, Treatment affordability

Full Text:

PDF

References


Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505-27.

Johnson LG, Armstrong A, Joyce CM, Teitelman AM, Buttenheim AM. Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review. Implement Sci. 2018;13(1):28.

Adekunle OO, Marliyya ZS, Sunday AA, Abimbola KO, Richard T, Habiba I, et al. The pattern of carcinoma of the vulva in Zaria, Northern Nigeria. Nigerian J Basic Clin Sci. 2016;13(1):46.

Globocan 2012 V1.0 Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11, 2013. Available at: http://globocan.iarc.fr/Default.aspx. Accessed on 10th December 2017.

Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol. 2015;6(6):281-90.

World Health Organization, World Health Organization. Reproductive Health, World Health Organization. Chronic Diseases, Health Promotion. Comprehensive cervical cancer control: a guide to essential practice. World Health Organization; 2006.

Mandong BM, Manasseh AN, Ayuba DM, Olugbenga SA, Emmanuel I, Kwaghe BV, et al. Burden of cancer in plateau state, central nigeria: a 27-year report from a tertiary hospital-based cancer registry. J Adv Med Medi Res. 2018:1-1.

Usman HA, Audu BM, Bukar M, Mayun A, Ibrahim SM. A five-year review of female genital tract malignancies at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. Bo Med J. 2017;14(2):152-8.

Sowunmi A, Alabi A, Fatiregun O, Olatunji T, Okoro US, Etti AF. Trend of cancer incidence in an oncology center in Nigeria. West African J Radiol. 2018;25(1):52.

World Poverty Clock. World Data Lab. 2018. Available at: https://worldpoverty.io/index.html. Accessed 22nd August 2019.

Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women’s cancers: a grand challenge in global health. The Lancet. 2017;389(10071):847-60.

Cheng ES, Weber M, Feletto E, Smith MA, Yu XQ. Cancer burden and control in Australia: lessons learnt and challenges remaining. Ann Cancer Epidemiol. 2018;2.

Yakasai IA, Ugwa EA, Otubu J. Gynaecological malignancies in Aminu Kano Teaching Hospital Kano: A 3 year review. Nig J Clin Pract. 2013;16:63-6.

Umeobika JC, Ikeako LC, Ezenyeaku CT, Ezenyeaku CT, Ezebialu UI, Ojiyi EC. Gynaecological malignant tumours at imo state university hospital Orlu South Eastern Nigeria. Afrimedic J. 2018;(6):52-8.

Usman HA, Audu BM, Kullima AA, Isa B, Ibrahim SM. A continuing tragedy of maternal mortality in a rural referral centre in Northeast Nigeria: A wake-up call. Trop J Obstet Gynaecol. 2018;35(1):18-24.

Usman HA, Audu BM, Ibrahim SM, Bukar M, Pindiga HU. Pattern of cancers at a rural referral centre in North-Eastern Nigeria. Bo Med J. 2018;15(1): 21-8.

Okeke TC, Onah N, Ikeako LC, Ezenyeaku CC. The frequency and pattern of female genital tract malignancies at the University of Nigeria Teaching Hospital, Enugu, Nigeria. Ann Med Health Sci Res. 2013;3(3):345-8.

Ouasmani F, Hanchi Z, Haddou Rahou B, Bekkali R, Ahid S, Mesfioui A. Determinants of patient delay in seeking diagnosis and treatment among Moroccan women with cervical cancer. Obstet Gynecol Inter. 2016;2016.

Eze JN, Emeka-Irem EN, Edegbe FO. A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria. Clinical Medicine Insights: Oncol. 2013;7:CMO-S12017.

Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79:954-62.

Aggarwal A, Unger-Saldaña K, Lewison G, Sullivan R. The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study. E Cancer Med Sci. 2015;9:536.